Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Gynecology

Free Subscription Articles published in Lancet Retrieve available abstracts of 162 articles: HTML format

Single Articles

February 2021
1. TAYLOR HS, Kotlyar AM, Flores VA
   Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.
   Lancet. 2021;397:839-852.
   PubMed     Abstract available
   
   
   January 2021
2. BOOTH A
   Honduras changes constitution to ban abortion.
   Lancet. 2021;397:360.
   PubMed    
   
   
   
3. LHEUREUX S, Cristea MC, Bruce JP, Garg S, et al
   Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
   Lancet. 2021;397:281-292.
   PubMed     Abstract available
   
   
   
4. BLAGDEN SP, Nicum S
   A source of hope for platinum-resistant ovarian cancer?
   Lancet. 2021;397:254-256.
   PubMed    
   
   
   
5. BOOTH A
   Argentina to legalise elective abortion.
   Lancet. 2021;397:82.
   PubMed    
   
   
   December 2020
6. CLARKE C
   Abortion and The Lancet's call to arms.
   Lancet. 2020;394:2241.
   PubMed    
   
   
   November 2020
7. GILBERT L, Miller K, Medeiros D, Tsatoumas M, et al
   A disease disregards anatomical planes: actinomycosis and an intrauterine device.
   Lancet. 2020;396:1766.
   PubMed    
   
   
   
8. CAMERON ST, Glasier A, McDaid L, Radley A, et al
   Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
   Lancet. 2020;396:1585-1594.
   PubMed     Abstract available
   
   
   
9. MARSTON C, Sowemimo A
   Bridge-It trial-a step towards better contraception services.
   Lancet. 2020;396:1536-1537.
   PubMed    
   
   
   September 2020
10. ALVES L
    Brazilian doctors condemn new rules on abortion.
    Lancet. 2020;396:808.
    PubMed    
    
    
    
11. SHAHAR-NISSAN K, Pardo J, Peled O, Krause I, et al
    Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;396:779-785.
    PubMed     Abstract available
    
    
    
12. LEVY L, Meuwly JY, Sarivalasis A, Achtari C, et al
    Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
    Lancet. 2020;396:725.
    PubMed    
    
    
    
13. EVANS DK, Acosta AM
    Lifting bans on pregnant girls in school.
    Lancet. 2020;396:667-668.
    PubMed    
    
    
    August 2020
14. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.
    PubMed    
    
    
    
15. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    PubMed     Abstract available
    
    
    
16. BARNHART K
    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    PubMed    
    
    
    
17. VON DADELSZEN P, Bhutta ZA, Sharma S, Bone J, et al
    The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis.
    Lancet. 2020;396:553-563.
    PubMed     Abstract available
    
    
    
18. POUCHOT J, Couprie A
    A wandering spleen, splenomegaly, hypersplenism, and iron deficiency anaemia.
    Lancet. 2020;396:412.
    PubMed    
    
    
    
19. CROVETTO F, Crispi F, Llurba E, Figueras F, et al
    Seroprevalence and presentation of SARS-CoV-2 in pregnancy.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31714.
    PubMed    
    
    
    
20. MAEDA Y, Ogawa K, Kamihara Y, Tanimoto T, et al
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:308.
    PubMed    
    
    
    
21. CHAPPELL LC, Juszczak E, Shennan A
    Managing late preterm pre-eclampsia - Authors' reply.
    Lancet. 2020;396:308-309.
    PubMed    
    
    
    
22. CARBILLON L
    Managing late preterm pre-eclampsia.
    Lancet. 2020;396:307-308.
    PubMed    
    
    
    July 2020
23. JAFFE S
    US Supreme Court upholds abortion rights, for now.
    Lancet. 2020;396:85-86.
    PubMed    
    
    
    
24. CLUVER CA, Herbst P, Griffith-Richards S, Hassan M, et al
    Coarctation of the aorta: a rare cause of severe hypertension in pregnancy.
    Lancet. 2020;396:62.
    PubMed    
    
    
    
25. MCGOVERN T
    US Global Gag Rule increases unsafe abortion.
    Lancet. 2020;396:24-25.
    PubMed    
    
    
    
26. GINSBURG O, Horton R
    A Lancet Commission on women and cancer.
    Lancet. 2020;396:11-13.
    PubMed    
    
    
    June 2020
27. ALLEN S, Cortina CS
    An unusual cause of breast hypertrophy: pseudoangiomatous stromal hyperplasia secondary to contraceptive implant.
    Lancet. 2020;395:1937.
    PubMed    
    
    
    
28. LADHANI SN, Lucidarme J, Parikh SR, Campbell H, et al
    Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis.
    Lancet. 2020;395:1865-1877.
    PubMed     Abstract available
    
    
    May 2020
29. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.
    PubMed    
    
    
    April 2020
30. PANCHAUD A, Favre G, Pomar L, Vouga M, et al
    An international registry for emergent pathogens and pregnancy.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30981.
    PubMed    
    
    
    March 2020
31. CHEN H, Guo J, Wang C, Luo F, et al
    Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
    Lancet. 2020;395:809-815.
    PubMed     Abstract available
    
    
    
32. QIAO J
    What are the risks of COVID-19 infection in pregnant women?
    Lancet. 2020;395:760-762.
    PubMed    
    
    
    
33. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    PubMed    
    
    
    February 2020
34. BURKI T
    UNAIDS and IAEA join forces on HIV and cervical cancer.
    Lancet. 2020;395:484.
    PubMed    
    
    
    
35. THE LANCET
    Appropriate care for pregnant women in Ebola outbreaks.
    Lancet. 2020;395:468.
    PubMed    
    
    
    
36. THE LANCET
    Preventing teenage pregnancies in Brazil.
    Lancet. 2020;395:468.
    PubMed    
    
    
    
37. TANIGUCHI Y, Nishikawa H, Maeda N, Terada Y, et al
    Breathlessness, pleural effusions, fibromas, and Meigs syndrome: look beyond the chest and don't delay!
    Lancet. 2020;395:e32.
    PubMed    
    
    
    
38. FAVRE G, Pomar L, Musso D, Baud D, et al
    2019-nCoV epidemic: what about pregnancies?
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30311.
    PubMed    
    
    
    
39. THE LANCET
    Eliminating cervical cancer.
    Lancet. 2020;395:312.
    PubMed    
    
    
    
40. UZOIGWE CE
    No global consensus among doctors or society on abortion.
    Lancet. 2020;395:e17.
    PubMed    
    
    
    
41. DUHIG K, Myers J, Seed PT, Shennan AH, et al
    Placental growth factor testing in suspected pre-eclampsia - Authors' reply.
    Lancet. 2020;395:336-337.
    PubMed    
    
    
    
42. KERMACK AJ, Stocker LJ, Coleman M
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335-336.
    PubMed    
    
    
    
43. TANNER M, Mol BW
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335.
    PubMed    
    
    
    
44. PHUMAPHI J, Gautam KC, Mason E
    Increased production and comprehensive guidelines needed for HPV vaccine.
    Lancet. 2020;395:319-321.
    PubMed    
    
    
    January 2020
45. CANFELL K, Kim JJ, Brisson M, Keane A, et al
    Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30157.
    PubMed     Abstract available
    
    
    
46. BRISSON M, Kim JJ, Canfell K, Drolet M, et al
    Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30068.
    PubMed     Abstract available
    
    
    
47. TSU VD
    Cervical cancer elimination: are targets useful?
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30219.
    PubMed    
    
    
    
48. HOFFMAN MK, Goudar SS, Kodkany BS, Metgud M, et al
    Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:285-293.
    PubMed     Abstract available
    
    
    
49. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    PubMed    
    
    
    
50. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    PubMed    
    
    
    November 2019
51. LYERLY AD
    Dolutegravir: advancing ethical research in pregnancy.
    Lancet. 2019;394:1972-1974.
    PubMed    
    
    
    
52. CLAMP AR, James EC, McNeish IA, Dean A, et al
    Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32259.
    PubMed     Abstract available
    
    
    
53. ESKANDER RN, Monk BJ
    Moving beyond cytotoxic drug dosing in ovarian cancer.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32948.
    PubMed    
    
    
    
54. CERDEIRA AS, Tome M, Moore N, Lim L, et al
    Seeing red degeneration in uterine fibroids in pregnancy: proceed with caution.
    Lancet. 2019;394:e37.
    PubMed    
    
    
    October 2019
55. O'NEILL D
    Abortion as a moral good?
    Lancet. 2019;394:1323-1324.
    PubMed    
    
    
    
56. MILLER D
    Hyaluronan-selected sperm should not be considered an add-on - Author's reply.
    Lancet. 2019;394:1320.
    PubMed    
    
    
    
57. PARMEGIANI L
    Hyaluronan-selected sperm should not be considered an add-on.
    Lancet. 2019;394:1319-1320.
    PubMed    
    
    
    September 2019
58. SUGIMURA K, Sasaki O, Shinoda M, Kawasaki S, et al
    Catamenial pneumothorax: a cause of monthly breathlessness.
    Lancet. 2019;394:952.
    PubMed    
    
    
    
59. SINGH S, Bougie O
    HEALTH for heavy menstrual bleeding: real-world implications.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)32086.
    PubMed    
    
    
    
60. COOPER K, Breeman S, Scott NW, Scotland G, et al
    Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31790.
    PubMed     Abstract available
    
    
    August 2019
61. KOTSOPOULOS J
    Menopausal hormones: definitive evidence for breast cancer.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31901.
    PubMed    
    
    
    
62. 
    Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Abstract available
    
    
    
63. BERAL V, Peto R, Pirie K, Reeves G, et al
    Menopausal hormone therapy and 20-year breast cancer mortality.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)32033.
    PubMed    
    
    
    
64. CHAPPELL LC, Brocklehurst P, Green ME, Hunter R, et al
    Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31963.
    PubMed     Abstract available
    
    
    
65. STAFF AC
    Long-term cardiovascular health after stopping pre-eclampsia.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31993.
    PubMed    
    
    
    
66. LAWRIE TA
    Prepregnancy calcium supplementation and pre-eclampsia - Author's reply.
    Lancet. 2019;394:e8.
    PubMed    
    
    
    
67. MAEDA Y, Suzuki Y, Yamamoto K, Tanimoto T, et al
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e7.
    PubMed    
    
    
    
68. PONZETTO A, Figura N, Riva P
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e6.
    PubMed    
    
    
    
69. HAIGH A, Haigh K
    Coroners' investigations of stillbirths.
    Lancet. 2019;394:564.
    PubMed    
    
    
    
70. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    PubMed    
    
    
    
71. CHAPPELL LC, Bell JL, Smith A, Linsell L, et al
    Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31270.
    PubMed     Abstract available
    
    
    
72. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    PubMed     Abstract available
    
    
    
73. MARSCHALL HU
    Ursodeoxycholic acid for intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31607.
    PubMed    
    
    
    July 2019
74. BURKI T
    Northern Ireland likely to legalise abortion.
    Lancet. 2019;394:290.
    PubMed    
    
    
    
75. HEMIDA R, van Doorn HC
    Avoid making a mountain out of an invasive hydatidiform mole: do a pregnancy test!
    Lancet. 2019;394:e2.
    PubMed    
    
    
    
76. CHATTERJEE P
    Hysterectomies in Beed district raise questions for India.
    Lancet. 2019;394:202.
    PubMed    
    
    
    June 2019
77. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    PubMed    
    
    
    
78. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    PubMed     Abstract available
    
    
    
79. SMIT JG
    Ongoing pregnancy as the primary outcome for the inSIGHT study.
    Lancet. 2019;393:2389.
    PubMed    
    
    
    
80. 
    HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31288.
    PubMed     Abstract available
    
    
    May 2019
81. THE LANCET
    We must all support women in the fight for abortion.
    Lancet. 2019;393:2099.
    PubMed    
    
    
    
82. JAFFE S
    Legal battles over abortion heat up in the USA.
    Lancet. 2019;393:1923-1924.
    PubMed    
    
    
    
83. LI A
    Northern Ireland deadlock impedes abortion rights progress.
    Lancet. 2019;393:1794.
    PubMed    
    
    
    
84. BUJOLD E, Chaillet N, Kingdom J
    Placental growth factor testing for suspected pre-eclampsia.
    Lancet. 2019;393:1775-1776.
    PubMed    
    
    
    
85. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed    
    
    
    
86. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    PubMed     Abstract available
    
    
    April 2019
87. THE LANCET
    Progress on investigating stillbirths.
    Lancet. 2019;393:1386.
    PubMed    
    
    
    
88. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
    Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
    PubMed     Abstract available
    
    
    March 2019
89. THE LANCET
    Gestational diabetes in England: cause for concern.
    Lancet. 2019;393:1262.
    PubMed    
    
    
    
90. WEI D, Liu JY, Sun Y, Shi Y, et al
    Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.
    Lancet. 2019;393:1310-1318.
    PubMed     Abstract available
    
    
    
91. LHEUREUX S, Gourley C, Vergote I, Oza AM, et al
    Epithelial ovarian cancer.
    Lancet. 2019;393:1240-1253.
    PubMed     Abstract available
    
    
    
92. WATSON K
    Abortion as a moral good.
    Lancet. 2019;393:1196-1197.
    PubMed    
    
    
    
93. LAUFER MK
    Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
    PubMed    
    
    
    
94. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    PubMed     Abstract available
    
    
    
95. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    PubMed    
    
    
    February 2019
96. KLEBANOFF MA
    Interpregnancy interval after stillbirth: modifiable, but does it matter?
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
    PubMed    
    
    
    
97. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
    Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
    PubMed     Abstract available
    
    
    
98. KIOKO PM, Meana PR
    Abortion in Argentina.
    Lancet. 2019;393:745.
    PubMed    
    
    
    
99. GARCIA G
    Abortion in Argentina.
    Lancet. 2019;393:744.
    PubMed    
    
    
    
100. UZOIGWE CE
     Abortion in Argentina.
     Lancet. 2019;393:744-745.
     PubMed    
     
     
     
101. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
     Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
     Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
     PubMed     Abstract available
     
     
     
102. PALMER KR, Xiaohua L, Mol BW
     Management of intrahepatic cholestasis in pregnancy.
     Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
     PubMed    
     
     
     
103. REPPING S
     Evidence-based medicine and infertility treatment.
     Lancet. 2019;393:380-382.
     PubMed    
     
     
     
104. MILLER D, Pavitt S, Sharma V, Forbes G, et al
     Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.
     Lancet. 2019;393:416-422.
     PubMed     Abstract available
     
     
     January 2019
105. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
     Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
     Lancet. 2019;393:330-339.
     PubMed     Abstract available
     
     
     
106. BUJOLD E, Hyett J
     Calcium supplementation for prevention of pre-eclampsia.
     Lancet. 2019;393:298-300.
     PubMed    
     
     
     
107. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
     Cervical cancer.
     Lancet. 2019;393:169-182.
     PubMed     Abstract available
     
     
     
108. THE LANCET
     Cervical cancer: unequal progress.
     Lancet. 2019;393:104.
     PubMed    
     
     
     December 2018
109. BERNITZ S, Dalbye R, Zhang J, Eggebo TM, et al
     The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.
     Lancet. 2018 Dec 20. pii: S0140-6736(18)31991.
     PubMed     Abstract available
     
     
     
110. DIAZ-GARCIA C, Pellicer A
     Uterus transplantation from a deceased donor.
     Lancet. 2018 Dec 4. pii: S0140-6736(18)32106.
     PubMed    
     
     
     
111. EJZENBERG D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, et al
     Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility.
     Lancet. 2018 Dec 4. pii: S0140-6736(18)31766.
     PubMed     Abstract available
     
     
     November 2018
112. THE LANCET
     Addressing preventable stillbirth and brain injury.
     Lancet. 2018;392:2238.
     PubMed    
     
     
     October 2018
113. FARQUHAR C
     Unexplained infertility - Authors' reply.
     Lancet. 2018;392:1517.
     PubMed    
     
     
     
114. GLEICHER N, Kuhnir VA, Barad DH
     Unexplained infertility.
     Lancet. 2018;392:1516-1517.
     PubMed    
     
     
     
115. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
     Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
     Lancet. 2018;392:1413-1422.
     PubMed     Abstract available
     
     
     
116. ADAMSON PC, Klausner JD
     No benefit of chlamydia screening in primary care?
     Lancet. 2018;392:1381-1383.
     PubMed    
     
     
     
117. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
     Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
     Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
     PubMed     Abstract available
     
     
     
118. KLEBANOFF MA, Brotman RM
     Treatment of bacterial vaginosis to prevent preterm birth.
     Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
     PubMed    
     
     
     September 2018
119. TEMMERMAN M, Lawn JE
     Stillbirths count, but it is now time to count them all.
     Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
     PubMed    
     
     
     
120. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
     Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
     Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
     PubMed     Abstract available
     
     
     August 2018
121. GRESSLER LE, Titus-Glover D, Shaya FT
     Treatment modalities for pregnant women with opioid use disorder.
     Lancet. 2018;392:551.
     PubMed    
     
     
     
122. SEN A, Nashef L
     New regulations to cut valproate-exposed pregnancies.
     Lancet. 2018;392:458-460.
     PubMed    
     
     
     July 2018
123. GHOSN J, Taiwo B, Seedat S, Autran B, et al
     HIV.
     Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
     PubMed     Abstract available
     
     
     
124. THE LANCET
     Cervical cancer prevention in Thailand-a model of success.
     Lancet. 2018;392:2.
     PubMed    
     
     
     June 2018
125. LI A
     From Ireland to Northern Ireland: campaigns for abortion law.
     Lancet. 2018;391:2403-2404.
     PubMed    
     
     
     
126. BOOTH A
     Argentina votes on bill to legalise abortion up to 14 weeks.
     Lancet. 2018;391:e21-e22.
     PubMed    
     
     
     
127. THE LANCET
     Dolutegravir for HIV: a lesson in pregnancy safety research.
     Lancet. 2018;391:2296.
     PubMed    
     
     
     May 2018
128. HALLGARTEN L
     Abortion narratives: moving from statistics to stories.
     Lancet. 2018 May 8. pii: S0140-6736(18)31036.
     PubMed    
     
     
     
129. SPERBER A
     El Salvador's total ban on abortion risks women's health.
     Lancet. 2018;391:1758-1759.
     PubMed    
     
     
     April 2018
130. BARNETT R
     Syphilis.
     Lancet. 2018;391:1471.
     PubMed    
     
     
     March 2018
131. THE LANCET
     Diagnosis of heavy menstrual bleeding: a change in direction.
     Lancet. 2018;391:1122.
     PubMed    
     
     
     
132. THE LANCET
     Abortion: access and safety worldwide.
     Lancet. 2018;391:1121.
     PubMed    
     
     
     
133. WATTS G
     New York Challenge sets high bar for HPV vaccination.
     Lancet. 2018;391:1137.
     PubMed    
     
     
     February 2018
134. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
     Management of pregnancy loss in the first trimester: a retrospective audit.
     Lancet. 2018;391 Suppl 2:S34.
     PubMed     Abstract available
     
     
     
135. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
     Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
     Lancet. 2018;391 Suppl 2:S26.
     PubMed     Abstract available
     
     
     
136. KATEEB E, Momany E
     Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
     Lancet. 2018;391 Suppl 2:S11.
     PubMed     Abstract available
     
     
     
137. LARSON HJ
     A global girl gang.
     Lancet. 2018;391:527-528.
     PubMed    
     
     
     
138. DEVI S
     FGM in Sierra Leone.
     Lancet. 2018;391:415.
     PubMed    
     
     
     December 2017
139. WEISS NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, et al
     Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.
     Lancet. 2017 Dec 19. pii: S0140-6736(17)33308.
     PubMed     Abstract available
     
     
     
140. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
     Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
     Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
     PubMed     Abstract available
     
     
     
141. KVASKOFF M, Horne AW, Missmer SA
     Informing women with endometriosis about ovarian cancer risk.
     Lancet. 2017;390:2433-2434.
     PubMed    
     
     
     November 2017
142. GHORANI E, Kaur B, Fisher RA, Short D, et al
     Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
     Lancet. 2017;390:2343-2345.
     PubMed    
     
     
     
143. NANDI A, El-Toukhy T
     Stimulated intrauterine insemination for unexplained subfertility.
     Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
     PubMed    
     
     
     
144. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
     Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
     Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
     PubMed     Abstract available
     
     
     
145. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
     Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
     Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
     PubMed     Abstract available
     
     
     
146. MABEY D, Marks M, Peeling R, Lawn J, et al
     Stillbirth caused by syphilis remains a major global health problem.
     Lancet. 2017;390:2036.
     PubMed    
     
     
     
147. HEININGER U
     Syphilis in children.
     Lancet. 2017;390:2035-2036.
     PubMed    
     
     
     October 2017
148. REGAN L, Glasier A
     The British 1967 Abortion Act-still fit for purpose?
     Lancet. 2017;390:1936-1937.
     PubMed    
     
     
     
149. YIN Y
     HPV vaccination in China needs to be more cost-effective.
     Lancet. 2017;390:1735-1736.
     PubMed    
     
     
     September 2017
150. CASASSUS B
     Contraception implant removed from global market.
     Lancet. 2017;390:1576.
     PubMed    
     
     
     
151. GEMZELL-DANIELSSON K, Cleeve A
     Estimating abortion safety: advancements and challenges.
     Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
     PubMed    
     
     
     
152. GANATRA B, Gerdts C, Rossier C, Johnson BR Jr, et al
     Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.
     Lancet. 2017 Sep 27. pii: S0140-6736(17)31794.
     PubMed     Abstract available
     
     
     
153. GARG SK, Polsky S
     Continuous glucose monitoring in pregnant women with type 1 diabetes.
     Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
     PubMed    
     
     
     
154. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
     Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
     Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
     PubMed     Abstract available
     
     
     
155. DIZON DS
     PARP inhibitors for targeted treatment in ovarian cancer.
     Lancet. 2017 Sep 12. pii: S0140-6736(17)32418.
     PubMed    
     
     
     
156. COLEMAN RL, Oza AM, Lorusso D, Aghajanian C, et al
     Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
     Lancet. 2017 Sep 12. pii: S0140-6736(17)32440.
     PubMed     Abstract available
     
     
     
157. DENNY L
     Nine-valent human papillomavirus vaccine: great science, but will it save lives?
     Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
     PubMed    
     
     
     
158. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
     Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
     Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
     PubMed     Abstract available
     
     
     July 2017
159. BANERJEE S
     Bevacizumab in cervical cancer: a step forward for survival.
     Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
     PubMed    
     
     
     
160. TEWARI KS, Sill MW, Penson RT, Huang H, et al
     Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
     Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
     PubMed     Abstract available
     
     
     April 2017
161. THE LANCET
     Syphilis: an ancient disease in a modern era.
     Lancet. 2017;389:1492.
     PubMed    
     
     
     December 2016
162. HOOK EW RD
     Syphilis.
     Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: